Michael Berk, MBBCh, MMed(Psych) Cum Laude, FF(Psych)SA, PhD, FRANZCP, Faculty of Health, School of Medicine, Deakin University; Stephanie Cowdery, BHSci, DLang, Grad Dip Psych(Hons), Lana Williams, BPsych, Grad Dip App Psych, MPsych (Clinical), PhD, IMPACT Strategic Research Centre, Faculty of Health, School of Medicine, Deakin University; Gin S. Malhi, MBChB, BSc(Hons), MD, FRCPsych, FRANZCP, CADE Clinic, North Shore Hospital, and Department of Psychiatry, University of Sydney, Australia
Michael Berk, MBBCh, MMed(Psych) Cum Laude, FF(Psych)SA, PhD, FRANZCP, Faculty of Health, School of Medicine, Deakin University; Stephanie Cowdery, BHSci, DLang, Grad Dip Psych(Hons), Lana Williams, BPsych, Grad Dip App Psych, MPsych (Clinical), PhD, IMPACT Strategic Research Centre, Faculty of Health, School of Medicine, Deakin University; Gin S. Malhi, MBChB, BSc(Hons), MD, FRCPsych, FRANZCP, CADE Clinic, North Shore Hospital, and Department of Psychiatry, University of Sydney, Australia.
Br J Psychiatry. 2017 Jul;211(1):1-2. doi: 10.1192/bjp.bp.116.193789.
Recent data might subtly recalibrate the risk/benefit ratio of lithium, the prototypical mood stabiliser for bipolar disorder. There are hints that lithium might be associated with a reduction in dementia risk and as noted in this , a surprising reduction in the risk of cancer.
最近的数据可能会微妙地调整锂（典型的双相情感障碍心境稳定剂）的风险/效益比。有迹象表明，锂可能与痴呆风险降低有关，正如这篇文章所指出的，癌症风险也出人意料地降低了。
